Royalty Report: Drugs, Pharmaceuticals, Biotechnology – Collection: 28996


Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 4

Primary Industries

  • Drugs
  • Pharmaceuticals
  • Biotechnology
  • Personal Care Products
  • Consumer Goods
  • Retail & Leisure
  • Healthcare
  • Cannabis

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 28996

License Grant
With effect from the Commencement Date, Australian Assignor as beneficial owner of the Invention assigns to the Australian Assignee to hold absolutely: its entire right, title and interest in and to the Invention, for agents in the treatment of skin wrinkles.
License Property
Assignor is the owner of Australian Provisional Patent Application PS0528, filed on 15 February 2002 – the invention titled Carbohydrate-based anti-wrinkle and tissue remodelling compounds.
Field of Use
Assignee wishes to purchase the rights to and commercialise the Invention.

IPSCIO Record ID: 3608

License Grant
Assignor, an individual, desires to sell, assign, transfer and convey to Assignee, its successors and assigns, Assignor's entire right, title and interest throughout the world in and to the Patent Application and patents issuing thereon to the full end of the term or terms of any said patents.
License Property
Assignor has made certain inventions relating to chimeric peptides.

Product shall mean all products, drugs, diagnostic reagents, diagnostic methods, therapeutic agents and therapeutic methods covered in whole or in part by a Valid Claim contained in any Patent.

Field of Use
Inventions and patent applications relate to the use of chimeric peptides for the treatment of Alzheimer’s disease.

IPSCIO Record ID: 28216

License Grant
Australian Licensor, an affiliate, hereby grants to Canadian Licensee an exclusive, world-wide sublicence under the Licensed Patent Applications and Licensed Patents, and an exclusive, world-wide sublicence under the New Intellectual Property, to use the Licensed Technology and to make, use and sell any products, compounds, compound uses, processes, applications, methods or procedures within the Field of Use.
License Property
'Licensed Patent Applications' means: (I) the patent applications relating to the invention entitled 'Novel phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity', including United State Patent Application No. 08/953305, Australian Application No. 41866/97 and any patent applications filed now or in the future in any country which disclose and claim the same inventions or the priority of Australian Provisional Application PO 3098/96, filed October 18, 1996.
Field of Use
'Field of Use' means arthritis and dermal wrinkles.

IPSCIO Record ID: 221664

License Grant
Assignor, Assignee's largest shareholder, hereby sells, assigns, and transfers to Assignee and Assignee’s successors: (a) all rights, title, and interests, to the Patent Application and all rights, title, and interests in any application and under any and all patents granted in the U.S. and abroad relating to the Patent Application, including but not limited to, all corresponding, provisional, continuation, continuation-in-part, divisional, reissue, and reexamination applications, for the entire term of the patent(s); (b) all rights, title, and interests in and to any and all foreign patents and applications for any invention described in the Patent Applications, in any and all countries foreign to the U.S., including all rights of priority arising from them, and all the rights and privileges under any and all forms of protection, including patents, that may be granted in said countries foreign to the U.S. for them for the entire term of the patent(s); and (c) the right to seek remedies for any and all infringements of any of the foregoing patents and to collect and retain all damages and profits and enjoy any and all remedies granted for infringements.

Assignee agrees to develop the Top-Shelf design into a working prototype and commence marketing, based on a timetable and a pre- approved cost structure, which shall be at the full discretion of the Assignee. Assignee shall have exclusive control over the timing, costs, sale and lease terms, marketing, development, and the rollout of Top Shelf product.

License Property
Assignor is the owner of the “Top Shelf” invention, as described in the United States Patent Application signed by Assignor on August 11, 2015, U.S. Patent and Trademark Office Serial Number 62/203,845, filed on August 11, 2015, and containing the following language (the Patent Application):

Apparatus for and method of securing, displaying, and dispensing herbal products including monitoring quantity and category of herbal products dispensed, and the persons who respectively dispensed and received each respective product.

The system allows for a dispensary operator to safely display product, secure product in an armored safe, weigh product in real-time using electronic scales housed in each of the locked compartments within the safe, and then dispense the product using an integrated Point-of-Sale, or POS System.

Assignor provides capital to our canna-business clientele and provide consulting services and technology to develop, enhance, and expand existing and newly formed canna-businesses.

Field of Use
This agreement pertains to the container industry relating to a apparatus for and method of securing, displaying, and dispensing herbal products.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.